Real-time Imaging of Endothelial Cell-cell Junctions During Neutrophil Transmigration Under Physiological Flow
August 14th, 2014
20.9K views
Leukocytes cross the endothelial monolayer using the paracellular or the transcellular route. We developed a simple assay to follow the distribution of endogenous junctional VE-cadherin and PECAM-1 during leukocyte transendothelial migration under physiological flow to discriminate between the two transmigration routes.
Overview
This study presents a novel assay to investigate the dynamics of leukocyte transendothelial migration under physiological flow conditions. By visualizing junctional proteins VE-cadherin and PECAM-1, the research aims to differentiate between paracellular and transcellular migration routes.
Key Study Components
Area of Science
- Cell biology
- Immunology
- Vascular biology
Background
- Leukocytes migrate across the endothelium via two primary routes: paracellular and transcellular.
- Understanding these routes is crucial for insights into immune responses and inflammation.
- VE-cadherin and PECAM-1 are key junctional proteins involved in endothelial cell adhesion.
- Current methods lack the ability to study these processes under physiological flow conditions.
Purpose of Study
- To develop an assay that allows real-time visualization of leukocyte migration.
- To differentiate between paracellular and transcellular migration routes.
- To enhance understanding of leukocyte behavior during inflammation.
Methods Used
- Isolation of polymorphonuclear leukocytes (PMNs) from healthy volunteers' blood.
- Use of fluorescently labeled antibodies to visualize junctional dynamics.
- Flow chamber setup to simulate physiological conditions.
- Confocal laser scanning microscopy for real-time observation of leukocyte behavior.
Main Results
- Successful visualization of leukocyte adhesion and transmigration.
- Identification of junctional dynamics in response to PMN migration.
- Demonstration of the assay's advantages over static methods.
- Insights into the preference of leukocytes for specific migration routes.
Conclusions
- The developed assay provides a valuable tool for studying leukocyte migration.
- Understanding the mechanisms of transmigration can inform therapeutic strategies for inflammatory diseases.
- The findings highlight the importance of physiological flow in leukocyte behavior studies.
Frequently Asked Questions
What is the significance of leukocyte transmigration?
Leukocyte transmigration is crucial for immune responses, allowing leukocytes to reach sites of inflammation.
How does the assay improve upon existing methods?
This assay allows for real-time observation under physiological flow, unlike static methods.
What are VE-cadherin and PECAM-1?
They are junctional proteins that play key roles in endothelial cell adhesion and leukocyte transmigration.
What type of microscopy is used in this study?
Confocal laser scanning microscopy is used for high-resolution imaging of leukocyte behavior.
What is the role of TNF-alpha in this experiment?
TNF-alpha is used to stimulate endothelial cells, promoting an inflammatory phenotype that enhances leukocyte adhesion.
Why is it important to study leukocyte migration under physiological conditions?
Studying under physiological conditions provides insights that are more relevant to in vivo situations, improving our understanding of immune responses.
Executive Industry Relevance
This assay enables real-time visualization of endothelial junctional dynamics under physiological flow, addressing a critical gap in modeling leukocyte transmigration for anti-inflammatory target validation. By distinguishing paracellular from transcellular migration routes, it provides mechanistic insights that support de-risking of therapeutic candidates targeting endothelial adhesion pathways. The approach enhances predictive confidence in preclinical models by replicating hemodynamic conditions relevant to post-capillary venules.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of VE-cadherin and PECAM-1 dynamics to clarify molecular mechanisms of leukocyte transmigration.
- Operational Value: Uses fluorescently labeled antibodies that do not interfere with junctional protein function, validated by impedance sensing and FRAP.
- Predictive Value: Supports hypothesis testing of whether compounds modulate paracellular versus transcellular leukocyte passage.
Screening & Assay Development
- Assay Readiness: Generates quantitative, real-time readouts of junctional protein redistribution during neutrophil transmigration under flow.
- Reproducibility: Standardized flow chamber setup with physiological shear stress (1–5 dynes/cm²) enables consistent leukocyte adhesion and transmigration measurements.
- Screening Utility: Facilitates compound screening for effects on endothelial barrier integrity and leukocyte migration routes.
Translational & Preclinical Research
- Disease Relevance: Models inflammatory conditions via TNF-α stimulation, upregulating adhesion molecules like ICAM-1 and VCAM-1.
- Translational Continuity: Bridges in vitro findings to in vivo leukocyte behavior by incorporating physiological flow, a key variable missing in static assays.
- Mechanistic De-risking: Clarifies whether test compounds affect junctional remodeling versus endothelial cell body penetration, informing target mechanism of action.
Pipeline & Workflow Integration
The method fits within the discovery continuum from target validation through lead optimization, particularly for immunomodulatory compounds where leukocyte endothelial interaction is a key pharmacodynamic biomarker.
- Discovery Biology: Supports pathway clarification by visualizing real-time junctional protein dynamics during leukocyte transmigration.
- Screening: Delivers quantitative, time-resolved imaging outputs that allow comparison of compound effects on migration route preference.
- Analytics: Enables measurement of junctional dispersion and recovery kinetics, providing statistical endpoints for comparing experimental conditions.
- Translational Research: Models human venous endothelium under flow, improving relevance to preclinical vascular inflammation models.
- Enterprise Reuse: Establishes a reusable platform for studying leukocyte-endothelial interactions across multiple antibody or small molecule programs.
Operational & Enterprise Impact
- Scientific Value: Reduces mechanistic ambiguity in leukocyte migration studies by directly visualizing junctional protein dynamics.
- Operational Value: Standardized protocol using flow chambers and confocal microscopy ensures reproducibility across laboratories.
- Strategic Value: Informs go/no-go decisions by identifying whether candidates preferentially block paracellular transmigration, a key anti-inflammatory mechanism.
- Portfolio Impact: Enables risk-adjusted prioritization of compounds based on effects on endothelial junctional stability under physiological conditions.
Implementation Considerations
- Requires expertise in cell culture, immunofluorescence staining, and microfluidic flow system setup.
- Dependent on confocal laser scanning microscopy with environmental control for temperature and CO₂.
- Necessitates standardization of TNF-α stimulation timing and antibody labeling protocols across users.
- Adaptation to other cell types or disease models may require validation of junctional marker specificity and flow compatibility.
- Practical limitations include the need for fresh primary neutrophil isolation and short-term antibody labeling windows to avoid functional perturbation.
Biopharma FAQs
Why is real-time imaging of VE-cadherin and PECAM-1 important for target validation?
Real-time imaging allows direct observation of junctional protein dynamics during neutrophil transmigration, enabling discrimination between paracellular and transcellular routes. This provides mechanistic clarity for evaluating how test compounds affect endothelial barrier function and leukocyte migration under physiological flow.
How does isolating the endothelial monolayer under flow improve discovery pipeline relevance?
Physiological flow conditions (1–5 dynes/cm²) better replicate in vivo hemodynamics in post-capillary venules, where leukocyte transmigration primarily occurs. This improves the predictive value of preclinical assays by reducing false positives from static systems that lack shear stress.
What quantitative measurements of junctional protein redistribution enable mechanistic de-risking?
The assay quantifies local dispersion and recovery of VE-cadherin and PECAM-1 at sites of diapedesis, providing measurable endpoints for junctional remodeling. These measurements help determine whether a compound stabilizes or disrupts endothelial junctions during leukocyte transmigration.
Why are replication requirements critical for cross-functional collaboration in assay adoption?
Standardized protocols for endothelial confluence, TNF-α stimulation, and antibody labeling ensure consistent junctional visualization across teams and sites. Reproducible flow shear stress and imaging settings allow reliable comparison of compound effects in multi-project screening campaigns.
What statistical analysis capabilities are required before implementing this assay in a screening cascade?
The assay generates time-series imaging data requiring statistical comparison of junctional fluorescence intensity, dispersion area, and recovery kinetics between control and treatment groups. Appropriate methods include mixed-effects models or ANOVA with post-hoc testing to account for donor variability and experimental replicates.
Chapters in this video
0:05
Title
1:59
Plating and Maintenance of Human Umbilical Vein Endothelial Cells
4:00
Polymorphonuclear Leukocyte Isolation Using Percoll Gradients
6:36
Labeling of Endothelial Junctional VE-cadherin and PECAM-1 and Performing the PMN TEM Assay Under Flow
9:24
Results: Visualization of the Dynamics of VE-cadherin and PECAM-1 During Neutrophil TEM
10:59
Conclusion
